Science & Innovation 10.03.2023
Amgen researchers use generative biology to accelerate and improve protein drug development by combining artificial intelligence and machine learning with automated, high-throughput lab-based science.
Responsibilty 09.29.2023
Leadership 09.28.2023
Science & Innovation 09.21.2023
Science & Innovation 09.20.2023
Responsibility 09.18.2023
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.